Press Releases

12345678910
AEO Inc. Declares a Regular Quarterly Dividend of $0.125 Per Share
American Eagle Outfitters, Inc. (NYSE: AEO) announced a quarterly cash dividend of $0.125 per share. The dividend was declared on March 2, 2026 and is payable on April 24, 2026 to stockholders of record at the close of business on April 10, 2026.
The Future of Business: Key Challenges CEOs Predict
The future of business is no longer shaped by slow, predictable cycles of growth and adjustment. Instead, it is defined by accelerating change, technological disruption, geopolitical complexity, and evolving stakeholder expectations. CEOs across industries are entering a period where adaptability is more valuable than certainty. The strategic conversations happening in boardrooms today revolve around resilience, digital transformation, workforce reinvention, and sustainable growth. Leaders recognize that the next decade will reward companies that can respond decisively to uncertainty while maintaining long term vision.
Via AB Newswire · March 4, 2026
Cialfir Group Enters the U.S. Market Under the Strategic Guidance of Martín Guijarro
BOCA RATON, FL - The Spanish multinational Cialfir Group, owner of the iconic pyrotechnics brand La Traca , has officially set its sights on North America. In a move that signals a bold new chapter in its corporate history, the group has initiated its expansion process into the United States, leveraging the strategic expertise of Marmagania LLC , a Florida-based consultancy led by industry veteran Martín Guijarro Paz .
Via Get News · March 4, 2026
Lawnade Lawn Care Joins the Grosse Pointe Chamber of Commerce
Lawnade Lawn Care is proud to announce its membership in the Grosse Pointe Chamber of Commerce, adding another chapter to a relationship with this community that goes back further than the business itself.
Via AB Newswire · March 4, 2026
The Operator Vault Publishes Free OpenClaw API Database for AI Agent Builders
FUNCHAL, Madeira - March 4, 2026 - The Operator Vault has released a free OpenClaw API database, now live at theoperatorvault.io/openclaw-apis, giving developers a centralized reference for APIs that are compatible with OpenClaw. The release targets one of the most consistent friction points in AI agent development: knowing which APIs actually work with OpenClaw before spending time testing integrations that were never built with it in mind.
Via AB Newswire · March 4, 2026
Five ways quantum technology shapes daily life
When most Australians hear the word “quantum”, they think of something futuristic. A lab experiment. A distant breakthrough. Perhaps something to do with quantum computers...?
Via AB Newswire · March 4, 2026
Workforce, AI And Inflation: Top CEO Concerns For 2026
As 2026 approaches, chief executive officers across industries are confronting a business landscape defined by rapid technological acceleration, persistent economic pressure, and a workforce undergoing structural transformation. The convergence of workforce evolution, artificial intelligence expansion, and inflationary volatility has created a leadership environment that demands sharper strategic thinking than ever before. CEOs are no longer navigating isolated challenges. Instead, they are managing interconnected forces that amplify one another, shaping operational decisions, capital allocation, talent strategy, and long term growth planning.
Via AB Newswire · March 4, 2026
40th Reunion for Cast of Aliens at Museum
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 4, 2026
40th Reunion for Cast of Aliens at Museum
GLENDALE, CA - March 4, 2026 (NEWMEDIAWIRE) - The Colonial Marines are assembling once again for a high-stakes mission in Southern California. Six cast members from the legendary 1986 cinematic masterpiece Aliens will reunite live and in person for “Aliens Invasion” on March 10 at the Martial Arts History Museum.
Via TheNewswire.com · March 4, 2026
Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results
REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025.
By Pulmonx Corporation · Via GlobeNewswire · March 4, 2026
What CEOs Say Are the Top Business Challenges in 2026
As we approach 2026, businesses face a landscape marked by unprecedented volatility, accelerated technological change, and shifting consumer expectations. CEOs and industry leaders agree that success will no longer be determined solely by growth ambitions, but by the ability to adapt, stay disciplined, and maintain trust. Unpredictability is becoming the norm—costs fluctuate, platforms evolve, and consumer behavior shifts in ways that challenge even the most prepared organizations. Companies that fail to establish resilient systems and clear operational processes risk falling behind in this fast-moving environment.
Via AB Newswire · March 4, 2026
Dot Ai Reports Fourth Quarter and Full Year 2025 Financial Results
Full Year Revenue Increases to $5.8 Million Driven by Accelerating Customer Adoption; Record Q4 Revenue Validates Commercial Momentum
Via ACCESS Newswire · March 4, 2026
Kingsway to Report Financial Results for Full Year 2025 on Thursday, March 12, 2026
CHICAGO, ILLINOIS / ACCESS Newswire / March 4, 2026 / (NYSE:KFS) Kingsway Financial Services Inc. ("Kingsway" or the "Company"), the only publicly-traded US company employing the Search Fund model to acquire and build great businesses, today announced that it will report financial results for the three and 12 months ended December 31, 2025, after the close of trading on Thursday, March 12, 2026.
Via ACCESS Newswire · March 4, 2026
MicroVision Announces Fourth Quarter and Full Year 2025 Results
REDMOND, WASHINGTON / ACCESS Newswire / March 4, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its fourth quarter and full year 2025 results.
Via ACCESS Newswire · March 4, 2026
LCI Industries Announces Participation in Upcoming Investor Conferences
LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today announced its participation in three upcoming investor conferences, including the Loop Capital Markets 7th Annual Investor Conference on March 9th, the Wolfe Research Small Group Conference on March 17th, and the 38th Annual Roth Conference on March 23rd. Lillian Etzkorn, Chief Financial Officer, will host investor meetings throughout the day at all three events, joined by Jason Lippert, President & Chief Executive Officer, at the Roth Conference.
By LCI Industries · Via Business Wire · March 4, 2026
Pasqal, A Global Leader in Neutral Atom Quantum Computing, to Go Public via Business Combination with Bleichroeder Acquisition Corp II
Pasqal Holding SAS (“Pasqal”), a global leader in neutral atom quantum computing, and Bleichroeder Acquisition Corp. II (“Bleichroeder”), a SPAC led and backed by Michel Combes and Andrew Gundlach (Nasdaq: BBCQ), announced today that they have entered into a definitive business combination agreement (“BCA”), following the consummation of which the go forward company will operate as Pasqal and is expected to be listed on Nasdaq. The proposed transaction is expected to close in the second half of 2026, subject to customary closing conditions, including regulatory and shareholder approval. As a global leader in neutral atom quantum computing, the deal values Pasqal at $2.0 billion pre-money, and contains $200 million in committed capital via convertible financing, which will allow Pasqal to deliver on its quantum roadmap and technology deployment, accelerate the Company’s efforts in demonstrating quantum advantage and accelerate international commercial and organizational growth.
Amprius Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Business Highlights
Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced financial results for the fourth quarter and full year ended December 31, 2025, and discussed recent business developments.
By Amprius Technologies, Inc. · Via Business Wire · March 4, 2026
AEO Inc. Reports Strong Fourth Quarter Fiscal 2025 Results; Provides Fiscal 2026 Outlook
American Eagle Outfitters, Inc. (NYSE: AEO) today announced financial results for the fourth quarter and fiscal year ended January 31, 2026, and provided its outlook for fiscal year 2026.
Stem Announces Fourth Quarter and Full Year 2025 Results
Stem, Inc. (“Stem,” “we,” or the “Company”) (NYSE: STEM), a global leader in clean energy software and services, today announced its financial results for the three and twelve months ended December 31, 2025.
By Stem, Inc. · Via Business Wire · March 4, 2026
ChargePoint Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
ChargePoint Holdings, Inc. (NYSE:CHPT) (“ChargePoint”), a global leader in electric vehicle (EV) charging solutions, today reported results for its fourth quarter and full fiscal year 2026 ended January 31, 2026.
By ChargePoint Holdings, Inc. · Via Business Wire · March 4, 2026
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the quarter and year-ended December 31, 2025, and recent corporate highlights.
By PepGen Inc. · Via Business Wire · March 4, 2026
Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, March 11th at 4:00 p.m. ET.
Savara Announces Participation in 2026 Citizens Life Sciences Conference
Savara Inc. (Nasdaq: SVRA) (the “Company”), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will participate in a fireside chat at the 2026 Citizens Life Sciences Conference on Wednesday, March 11th at 10:10am ET in Miami, FL.
By Savara Inc. · Via Business Wire · March 4, 2026
J.B. Hunt Transport Services, Inc. Announces Participation in Upcoming Investor Conference
J.B. Hunt Transport Services, Inc.’s (NASDAQ: JBHT) Executive Vice President and President of Intermodal Darren Field and Chief Financial Officer and Executive Vice President of Finance Brad Delco will address the J.P. Morgan Industrials Conference in Washington, D.C., at 9:30 a.m. EDT on Tuesday, March 17, 2026.
flyExclusive Reports Fourth Quarter and Full-Year 2025 Results
flyExclusive, Inc. (NYSEAMERICAN: FLYX), a leading provider of premium private jet experiences, announced it will release fourth quarter and full-year 2025 financial results through a Form 10-K to be filed with the Securities and Exchange Commission (SEC) before the market open on March 5, 2026. When filed, the Form 10-K can be found at https://ir.flyexclusive.com/sec-filings or at www.sec.gov. When filed, a supplemental presentation of fourth quarter and full-year results can also be found on the Financial Results section of our Investor Relations website here https://ir.flyexclusive.com/financial-information/financial-results.
By flyExclusive, Inc. · Via Business Wire · March 4, 2026
Rigetti Computing Reports Fourth Quarter and Full-Year 2025 Financial Results
Demonstrates 99.9% two-qubit gate fidelity at 28 nanosecond gate speed on prototype platform
By Rigetti Computing, Inc. · Via GlobeNewswire · March 4, 2026
Janus International Group Reports Fourth Quarter and Full Year 2025 Financial Results
Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading global manufacturer and provider of turnkey self-storage, commercial, and industrial building solutions, today announced financial results for its fiscal fourth quarter and full year ended January 3, 2026.
OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the quarter and year ended December 31, 2025, and provided operating and partner program updates.
By OmniAb, Inc. · Via Business Wire · March 4, 2026
Universal Electronics Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 12th
Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in wireless universal control solutions for home entertainment and smart home devices, will host a conference call at 4:30 p.m. ET on Thursday, March 12, 2026, to discuss its fourth quarter 2025 financial results. Management will provide a financial and business update as well as answer questions.
By Universal Electronics Inc. · Via Business Wire · March 4, 2026
WSFS Management to Participate in the 2026 RBC Capital Markets Global Financial Institutions Conference
WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in the 2026 RBC Capital Markets Global Financial Institutions Conference on March 11, 2026, in New York City. David Burg, Executive Vice President, Chief Financial Officer, Arthur J. Bacci, Executive Vice President, Chief Operating Officer, and Andrew Basile, Vice President, Head of Investor Relations will host discussions with investors.
By WSFS Financial Corporation · Via Business Wire · March 4, 2026
James River Recruits Industry Veteran Kelly Hadiaris to Lead Excess Casualty
CHAPEL HILL, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Kelly Hadiaris has re-joined the Company as Senior Vice President, Underwriting – Excess Casualty, to lead the Excess Casualty division within its Excess and Surplus (“E&S”) segment. Ms. Hadiaris will report to Todd Sutherland, President of the E&S segment.
Pulmonx Announces Closing of up to $60 Million Credit Facility
Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn Capital
By Pulmonx Corporation · Via GlobeNewswire · March 4, 2026
BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the fourth quarter and full year ended December 31, 2025 and raised guidance for full year 2026.
By BillionToOne, Inc. · Via GlobeNewswire · March 4, 2026
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
By Teladoc Health, Inc. · Via GlobeNewswire · March 4, 2026
Coherent Launches 224Gbps Quad TIA for Next-Generation AI and Cloud Infrastructure
SAXONBURG, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its CHR1074 224Gbps quad-channel transimpedance amplifier (TIA) designed to power next-generation 800G and 1.6T optical transceivers. Engineered for high-performance AI and cloud infrastructure, the CHR1074 combines ultra-fast link recovery with intelligent power management to improve efficiency and reduce latency in increasingly dynamic data center environments.
By Coherent Corp. · Via GlobeNewswire · March 4, 2026
NCS Multistage Holdings, Inc. Announces Fourth Quarter and Full Year 2025 Results
Fourth Quarter Results
By NCS Multistage Holdings, Inc. · Via GlobeNewswire · March 4, 2026
red violet Announces Fourth Quarter and Full Year 2025 Financial Results
Fourth Quarter Revenue Increased 20% to a Record $23.4 Million
By Red Violet, Inc. · Via GlobeNewswire · March 4, 2026
Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference
IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steven Perrin, Ph.D., President and Chief Scientific Officer, will participate in a fireside chat at the upcoming Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026, at 1:40 p.m. ET (10:40 a.m. PT).
By Eledon Pharmaceuticals, Inc. · Via GlobeNewswire · March 4, 2026
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on March 2, 2026, the Company granted restricted stock units (RSUs) representing 50,700 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.
By Fate Therapeutics, Inc. · Via GlobeNewswire · March 4, 2026
Samsung theSUITE Supports Healthcare Professional Skills with Comprehensive Free Ultrasound Education Platform
Free global platform provides healthcare professionals with 1,000+ premium courses and clinical images, including specialized training on AI-enhanced ultrasound diagnostics
Via AB Newswire · March 4, 2026
Industry Analyst: MWC 2026 ushers in new AI – 5G – 6G Era to wireless world
MWC Barcelona 2026 offers a clear preview of what is coming next as artificial intelligence and 5G converge to reshape the wireless industry. Each year, global trade shows like Mobile World Congress in Barcelona usher in new thinking, fresh ideas, and breakthrough technologies for the wireless industry. In 2026, AI and 5G stand side by side, with powerful demonstrations of how they will transform both the industry and our everyday lives.
Via AB Newswire · March 4, 2026
Smith Micro Announces Tim Huffmyer to Succeed Bill Smith as President and CEO
Smith Micro Software, Inc. (Nasdaq: SMSI) today announced that it has named current Chief Operating Officer and Chief Financial Officer Tim Huffmyer to serve as Smith Micro’s next President and Chief Executive Officer. Huffmyer will assume the role from Bill Smith, who has been appointed to the role of Executive Chairman. The changes will take effect on March 31, 2026 and follow leadership succession planning led by Smith and the Company’s Board of Directors.
By Smith Micro Software, Inc. · Via Business Wire · March 4, 2026
PepGen Announces Regulatory Updates on FREEDOM2
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological diseases, today announced regulatory updates related to the FREEDOM2 trial.
By PepGen Inc. · Via Business Wire · March 4, 2026
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced its fourth quarter and fiscal year 2025 financial results.
By Niagen Bioscience, Inc · Via Business Wire · March 4, 2026
Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results
Cardlytics, Inc. (NASDAQ: CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025.
By Cardlytics, Inc. · Via Business Wire · March 4, 2026
Smith Micro Announces Investment Led by CEO and Founder, Bill Smith
Smith Micro Software, Inc. (the “Company” or “Smith Micro”) (NASDAQ: SMSI) today announced that it has entered into a securities purchase agreement for the sale of securities to accredited investors pursuant to an unregistered offering, the gross proceeds of which are expected to be approximately $4.9 million, which includes committed investments of approximately $4.6 million from a trust for which Bill Smith, the Company’s chief executive officer and founder, serves as co-trustee, and approximately $90 thousand from Tim Huffmyer, the Company’s chief operating officer and chief financial officer.
By Smith Micro Software, Inc. · Via Business Wire · March 4, 2026
Sunline Kitchen Remodeling Experts Share Homeowner Guide to Kitchen Renovations in Boynton Beach, Florida
Boynton Beach, FL - As homeowners across South Florida invest in home improvements that enhance both comfort and property value, experts at Sunline Kitchen Remodeling are encouraging residents to plan a professional Kitchen Remodel to modernize outdated kitchens and improve daily functionality. According to housing industry reports, kitchen renovations remain one of the most valuable home upgrades, often delivering some of the highest returns on investment among residential improvement projects.
Via AB Newswire · March 4, 2026
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that Alexion Pharmaceuticals, Inc. (the “Licensee”) informed Xencor, Inc. (the “Company”) that it has taken the position that the Licensee does not owe any additional royalties for sales of Ultomiris® (ravulizumab-cwvz) in the United States and that the Licensee does not intend to make any future payments for sales in the United States. The Licensee informed the Company that it intends to continue making royalty payments for sales of Ultomiris outside the United States.
By Xencor, Inc. · Via Business Wire · March 4, 2026
Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three months and full year ended December 31, 2025, and highlighted recent progress.
By Verastem Oncology · Via Business Wire · March 4, 2026
Magnachip Reports Results for Fourth Quarter and Full-Year 2025
Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced financial results for the fourth quarter and full year 2025.